EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RASSF1A polymorphism in familial breast cancer



RASSF1A polymorphism in familial breast cancer



Familial Cancer 9(3): 263-265



Inactivation or loss of the tumour suppressor Ras associated domain family 1 isoform A (RASSF1A) allele has been described in breast cancer. Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers. We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women. The RASSF1A p.A331S variant was not more common in the familial breast cancer cases than in the controls (P = 0.27). Subset analysis demonstrated no association in the BRCA1 (P = 0.26), BRCA2 (P = 0.16) or BRCA negative (P = 0.30) samples. Hence, the RASSF1A p.A331S polymorphism is not confirmed as a significant germline contributor to familial breast cancer susceptibility.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333486

Download citation: RISBibTeXText

PMID: 20361264

DOI: 10.1007/s10689-010-9335-8



Related references

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Research 68(1): 22-25, 2008

Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients. Iranian Biomedical Journal 13(4): 199-206, 2010

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. Bmc Cancer 12: 243-243, 2013

Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention 18(10): 2723-2725, 2010

A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast. International Journal of Oncology 27(1): 185-191, 2005

Polymorphism of the c-Ha-ras-1 proto-oncogene in sporadic and familial breast cancer. International Journal of Cancer 44(2): 251-255, 1989

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Letters 168(1): 31-36, July 10, 2001

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29(10): 1963-1966, 2008

Management of familial breast cancer part 1 bio statistical genetic aspects and their limitations as derived from a familial breast cancer resource. Archives of Surgery 113(9): 1053-1058, 1978

Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. European Journal of Surgical Oncology 41(5): 641-646, 2015

Management of familial breast cancer. I. Biostatistical-genetic aspects and their limitations as derived from a familial breast cancer resource. Archives of Surgery 113(9): 1053-1058, 1978

Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast Cancer Research and Treatment 113(3): 607-608, 2008

An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Research and Treatment 99(3): 257-265, 2006